Ann Flynn
( out of 65 reviews )

Ann Flynn, MD

Languages spoken: English

Clinical Locations

South Jordan Health Center

South Jordan
801-213-4500

Gastroenterology /GI Clinic UUH

Gastroenterology, Area E
Salt Lake City
801-213-9797

  • Dr. Flynn attended medical school at New York Medical College. She completed internal medicine residency training at the University of Colorado School of Medicine and gastroenterology fellowship training at the Indiana University School of Medicine. She completed an advanced fellowship in inflammatory bowel disease at Indiana University. Her clinical interests include diagnosis and management of inflammatory diseases of the GI tract including Crohn's disease, ulcerative colitis, and microscopic colitis. She is passionate about women's GI health, shared decision-making discussions, patient education, personalized care for patients with inflammatory bowel disease, and assisting patients transitioning care from pediatric to adult GI clinics. Dr. Flynn is a member of the American College of Gastroenterology Patient Care Committee and the Crohn's and Colitis Foundation Patient Education Committee. She currently serves as the American College of Gastroenterology Governor for Utah.

    The University of Utah Inflammatory Bowel Disease Program is a participating site in IBD Qorus, a collaboration between patients and healthcare providers to improve the quality of IBD care across the country, to ensure all patients receive the highest quality IBD care, treatment, and disease outcomes. Dr. Flynn serves as the IBD Qorus physician leader for the University of Utah.

    Dr. Flynn is board certified in Gastroenterology. She is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the Crohn’s and Colitis Foundation.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Gastroenterology)

    Patient Rating

    4.9 /5
    ( out of 65 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 02, 2024
    UH HOSPITALS AND CLINICS

    Dr Flynn has been amazing at providing care and being very professional.

    September 24, 2024
    UH HOSPITALS AND CLINICS

    Dr Flynn really cares about her patient's. She has worked to find solutions for my issues and has helped me get my life back!

    September 21, 2024
    UH HOSPITALS AND CLINICS

    Dr Flynn is awesome, she's a great doctor. She always includes you in your care decisions. She has always been great in understanding that each patient knows their body and takes that into her account when you are coming to decisions about what care is best for you as an individual.

    September 13, 2024
    UH HOSPITALS AND CLINICS

    The best decision of my life was to switch hospitals from where I currently live to the University of Utah. Dr. Ann Flynn in Gastroenterology has saved my life. I went through roughly 2 years of my home Dr's putting me on all these different pills and nothing worked. It was the worst 2 years of my life dealing with all the pills and side affects. The first day I sat down with Dr. Flynn she recommended one medication for me and it has been a game changer. I have had zero problems since Dr. Flynn came into my life. She is brilliant!! She gave me a second chance at life!! She has been the greatest Dr. I have ever had!! Life was so hard and miserable for me before meeting her. I am so grateful for Dr. Flynn and for the love and care she shows. It's good to have a Dr. that cares and knows what they are doing. Thank you Dr. Ann Flynn for giving me a better life. You truly are amazing!! Jeremy

    July 20, 2024
    UH HOSPITALS AND CLINICS

    Dr. Flynn is, by far, the best gastroenterologist I have ever dealt with. Will never go anywhere else but the U ever again! Best care by far!

    June 08, 2024
    UH HOSPITALS AND CLINICS

    Cared about why I was there and listened carefully. Working with me to get to the bottom of my medical issues.

    June 07, 2024
    UH HOSPITALS AND CLINICS

    I love Dr. Flynn. As a medically complicated patient, it's easy for doctors to have tunnel vision and ignore everything except the condition they specialize in and then suggest treatment options that just don't make sense with my other conditions. That's not Dr. Flynn. She is always very good at seeing me as a whole and tailoring IBD treatments suggestions to my own needs. She's a great listener and it's very obvious that she understands the lived experiences of people with IBD. Plus, she's just fun. I really can't say enough good things.

    April 27, 2024
    UH HOSPITALS AND CLINICS

    Dr Flynn is compassionate and professional. She truly cares about her patients.

    April 19, 2024
    UH HOSPITALS AND CLINICS

    Dr. Ann Flynn was amazing

    See More Patient Comments

  • Dr. Flynn attended medical school at New York Medical College. She completed internal medicine residency training at the University of Colorado School of Medicine and gastroenterology fellowship training at the Indiana University School of Medicine. She completed an advanced fellowship in inflammatory bowel disease at Indiana University. Her clinical interests include diagnosis and management of inflammatory diseases of the GI tract including Crohn's disease, ulcerative colitis, and microscopic colitis. She is passionate about women's GI health, shared decision-making discussions, patient education, personalized care for patients with inflammatory bowel disease, and assisting patients transitioning care from pediatric to adult GI clinics. Dr. Flynn is a member of the American College of Gastroenterology Patient Care Committee and the Crohn's and Colitis Foundation Patient Education Committee. She currently serves as the American College of Gastroenterology Governor for Utah.

    The University of Utah Inflammatory Bowel Disease Program is a participating site in IBD Qorus, a collaboration between patients and healthcare providers to improve the quality of IBD care across the country, to ensure all patients receive the highest quality IBD care, treatment, and disease outcomes. Dr. Flynn serves as the IBD Qorus physician leader for the University of Utah.

    Dr. Flynn is board certified in Gastroenterology. She is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the Crohn’s and Colitis Foundation.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Internal Medicine (Sub: Gastroenterology)

    Education history

    Fellowship Inflammatory Bowel Disease - Indiana University Advanced Fellow
    Fellowship Gastroenterology and Hepatology - Indiana University Chief Fellow
    Fellowship Gastroenterology and Hepatology - Indiana University Fellow
    Residency Internal Medicine - University of Colorado at Denver Resident
    Internship Internal Medicine - University of Colorado at Denver Intern
    Professional Medical Alpha Omega Alpha - New York Medical College M.D.
    Undergraduate Molecular Biology, Senior Thesis: Identification of Genes Involved in Fab-7 boundary function by F2 EMS Mutagenesis Screen. - Princeton University A.B.

    Selected Publications

    Journal Article

    1. Levic DS, Niedzwiecki D, Kandakatla A, Karlovich NS, Juneja A, Park J, Stolarchuk C, Adams S, Willer JR, Schaner MR, Lian G, Beasley C, Marjoram L, Flynn AD, Valentine JF, Onken JE, Sheikh SZ, Davis EE, Evason KJ, Garman KS, Bagnat M (2024). TNF promoter hypomethylation is associated with mucosal inflammation in IBD and anti-TNF response.  medRxiv (preprint)  2024 Feb 6:2024. medRxiv.
    2. Pozdnyakova V, Botwin GJ, Sobhani K, Prostko J, Braun J, Mcgovern DPB, Melmed GY, Appel K, Banty A, Feldman E, Ha C, Kumar R, Lee S, Rabizadeh S, Stein T, Syal G, Targan S, Vasiliauskas E, Ziring D, Debbas P, Hampton M, Mengesha E, Stewart JL, Frias EC, Cheng S, Ebinger J, Figueiredo JC, Boland B, Charabaty A, Chiorean M, Cohen E, Flynn A, Valentine J, Fudman D, Horizon A, Hou J, Hwang C, Lazarev M, Lum D, Fausel R, Reddy S, Mattar M, Metwally M, Ostrov A, Parekh N, Raffals L, Sheibani S, Siegel C, Wolf D, Younes Z (2021). Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease. Gastroenterology, 161(6), 2041-2043.e1. (Read full article)
    3. Almario CV, Kogan L, van Deen WK, Scott FI, Singh S, Hou JK, Lum D, Aguilar H, Betteridge J, Flynn A, Gerich M, Kaufman L, Mattar MC, Mize C, Ostrov A, Shah SA, Younes Z, Weaver SA, Heller C, Siegel CA, Melmed GY (2021). Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease. Am J Gastroenterol, 116(12), 2459-2464. (Read full article)
    4. Almario CV, Kogan L, van Deen WK, Scott FI, Singh S, Hou JK, Lum D, Aguilar H, Betteridge J, Flynn A, Gerich M, Kaufman L, Mattar MC, Mize C, Ostrov A, Shah SA, Younes Z, Weaver SA, Heller C, Siegel CA, Melmed GY (2021). Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease. Am J Gastroenterol, 116(12), 2459-2464. (Read full article)
    5. Lewis JD, Sandler RS, Brotherton C, Brensinger C, Li H, Kappelman MD, Daniel SG, Bittinger K, Albenberg L, Valentine JF, Hanson JS, Suskind DL, Meyer A, Compher CW, Bewtra M, Saxena A, Dobes A, Cohen BL, Flynn AD, Fischer M, Saha S, Swaminath A, Yacyshyn B, Scherl E, Horst S, Curtis JR, Braly K, Nessel L, McCauley M, McKeever L, Herfarth H (2021). A Randomized Trial Comparing the SpecificCarbohydrate Diet to a Mediterranean Diet in Adults with Crohn's Disease.PMID: 34052278. Gastroenterology, 161(3), 837-852.
    6. Lewis JD, Sandler R, Brotherton C, Brensinger C, Li H, Kappelman MD, Daniel SG, Bittinger K, Albenberg L, Valentine JF, Hanson J, Suskind D, Meyer A, Compher CW, Bewtra M, Saxena A, Dobes A, Cohen B, Flynn AD, Fischer M, Saha S, Swaminath A, Yacyshyn B, Scherl E, Horst S, Curtis JR, Braly K, Nessel L, McCauley M, McKeever L, Herfarth H, DINE-CD Study Group (2021). A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults with Crohn's Disease. Gastroenterology, 161, 837-852.e9. (Read full article)
    7. Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer M (2018). Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Am J Transplant, 19(2), 501-511. (Read full article)
    8. DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD (2008). Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med, 23(2), 169-74. (Read full article)

    Review

    1. Gawron LM, Sanders J, Steele K, Flynn A (2016). Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases. [Review]. Inflamm Bowel Dis, 22(2), 459-64.

    Letter

    1. Andea Banty, Edward Feldman, Christina Ha, Susie Lee, Shervin Rabizadeh, Theodore Stein, Theodore Solomon, Gaura Syal, Stephan Targan, Eric Vasiliauskas, David Ziring, Niru Bonthala, Gregory S Botwin, Melissa Hampton, Emebet Mengesha, Elizabeth Khanishian, Valeriya Pozdnyakova, Phillip Gu, Angela Mujukian, Shane White, Cindy Zamudio, Daniel Gonzalez, Alyssa Parry, Mary Hanna, Justin Chan, Joe Ebinger, Sandy Joung, Min Wu, Amu Hoang, Timothy Wynter, Nancy Sun, Jane C Figueiredo, Akil Merchant, Noah Merin, Karen L Reckamp, Keren Appel, Rashmi Kumar, Brigid Boland, Aline Charabaty, Michael Chiorean, Erica Cohn, Ann Flynn, John Valentine, Adam C Ehrlich, David Fudman, Arash Horizon, Dmitry Karayev, Benjamin Kretzmann, Jason Hou, Caroline Hwany, Mark Lazarev, Donald Lum, Rebecca Fausel, Swapna Reddy, Ryan McConnell, Mark C Mattar, Mark Metwally, Arthur Ostrov, Nimisha Parekh, Laura Raffals, David T Rubin, Sarah Sheibani, Corey A Siegel, Douglas Wolf, Ziad Youness (). Post-Vaccination Symptomsafter a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease [Letter to the editor]. Gastroenterology.
    2. Gil Y Melmed, Dalin Li, Philip Debbas, Susan Cheng, Jonathan Braun, Dermot PB McGovern (). Post-Vaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease [Letter to the editor]. Research Letter Cedars-Sinai Medical Center.

    Abstract

    1. Melmed G, Hou JK, Lum D, Gerner D, Singh S, Crate DJ, Holthoff M, Kennedy AM, Aguilar H, Almario CV, Banty A, J Betteridge, Bhatti F, Bray H, Charabaty A, Dudley-Brown S, Fasanya-Uptagraft H, Fausel R, Fennimore B, Flynn AD, Gerich ME, Ghafari A, Ha C, Heagy E, Hudesman D, Hwang C, Kaufman L, Kaur N, Kim B, Mattar M, McCutcheon Adams K, Mehta F, Metwally M, Oliver BO, Ostrov A, Reddy S, Rubin DT, Scott FI, Shah S, Syal G, Valentine JF, van Deen WK, Vrabie R, Wang A, Williams E, Younes ZH, Yun L, Zisman T, Farraye FA, Nelson E, Heller C, Oberai R, Weaver A, Siegel CA (2020). Quality of Care Initiative Improves Outcomes for Patients with Inflammatory Bowel Disease.   [Abstract]. 158(6), S-8-S-9.
    2. Melmed G, Hou JK, Lum D, Gerner D, Singh S, Crate DJ, Holthoff M, Kennedy AM, Aguilar H, Almario CV, Banty A, J Betteridge, Bhatti F, Bray H, Charabaty A, Dudley-Brown S, Fasanya-Uptagraft H, Fausel R, Fennimore B, Flynn AD, Gerich ME, Ghafari A, Ha C, Heagy E, Hudesman D, Hwang C, Kaufman L, Kaur N, Kim B, Mattar M, McCutcheon Adams K, Mehta F, Metwally M, Oliver BO, Ostrov A, Reddy S, Rubin DT, Scott FI, Shah S, Syal G, Valentine JF, van Deen WK, Vrabie R, Wang A, Williams E, Younes ZH, Yun L, Zisman T, Farraye FA, Nelson E, Heller C, Oberai R, Weaver A, Siegel CA (2020). The IBD Urgent Care Toolkit: Which Process Changes are Associated with Successful Improvement? [Abstract]. 158(6), S-411.
    3. Melmed G, Hou JK, Lum D, Gerner D, Singh S, Crate DJ, Holthoff M, Kennedy AM, Aguilar H, Almario CV, Banty A, J Betteridge, Bhatti F, Bray H, Charabaty A, Dudley-Brown S, Fasanya-Uptagraft H, Fausel R, Fennimore B, Flynn AD, Gerich ME, Ghafari A, Ha C, Heagy E, Hudesman D, Hwang C, Kaufman L, Kaur N, Kim B, Mattar M, McCutcheon Adams K, Mehta F, Metwally M, Oliver BO, Ostrov A, Reddy S, Rubin DT, Scott FI, Shah S, Syal G, Valentine JF, van Deen WK, Vrabie R, Wang A, Williams E, Younes ZH, Yun L, Zisman T, Farraye FA, Nelson E, Heller C, Oberai R, Weaver A, Siegel CA (2020). Improvement in Inflammatory Bowel Disease Care Does Not Differ by Practice Type. [Abstract]. 158(6), S-412.
    4. Youngblood BA, Butuci M, Davis T, Xu A, Schanin J, Brock EC, Singh B, Rasmussen HS, Holman A, Drake R, Peterson K, Flynn AD (2020). Phenotypic Characterization of Inflammatory Bowel Disease Biopsies Reveal That Mast Cells Are Significantly Elevated and Activated In Patients with Ulcerative Colitis   [Abstract]. 26(Supplement 1), S33-34.

    Video/Film/CD/Web/Podcast

    1. Flynn, AD, Mattar, MC (2021). Understanding the Treat to Target Approach and Effective Partnering in IBD Care, https://youtu.be/i_Btj0Z6LF8 [Video]. YouTube, Crohns and Colitis Foundation Website: Crohn's and Colitis Foundation.
    2. Flynn AD (2020). Young Adults: Managing the Cost of IBD Medications and Treatment, https://www.youtube.com/watch?v=P1FfArmMATM  [Video]. Crohn's and Colitis Foundation.
    3. Diet and Nutrition Initiative, Flynn A, Eichelberger K, Issokson K, Shah R, Yen E (2018). "IBD: Diet and Nutrition." Materials developed include webinar, animated videos, webpages, website, educational graphics, and an e-tool/game to provide patient education regarding malnutrition, food choices, nutritional support therapy, vitamin supplementation, and current research concerning diet and inflammatory bowel disease. Animated video topics include, "Malnutrition and IBD," "What to Eat when in a Flare," "What to Eat when in Remission," "Nutrition Support Therapy," and "Vitamin and Mineral Supplementation." A webinar on Complementary and Alternative Medicine for IBD is currently in development. [Web]. Crohn's and Colitis Foundation. Available: http://www.crohnscolitisfoundation.org/what-are-crohns-and-colitis/diet-and-nutrition/.
    4. Financial Management Workgroup, Mattar M, Flynn A, Parian A, Seminerio S, Taleban S, Ha T (2018). "Managing the Cost of IBD." Web-based materials for patients and caregivers managing IBD finances. Topics include understanding health insurance, financial assistance programs, what to do if you are denied coverage, creation of updated appeal letter templates. [Web]. Crohn's and Colitis Foundation. Available: www.crohnscolitisfoundation.org/managingcosts.
    5. Ausk K, Flynn A, Fennimore B (September 2016). Thinking about Colorectal Cancer. Understanding the Risks and Prevention. [Video]. Crohn's and Colitis Foundation of America. Available: https://youtu.be/uYCK7kZUbs8.